Clinical Trials › NCT06599307
RecruitingPhase 2
The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis
Sponsored by Cairo University
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 46
Target enrollment
Aug 2024
Start date
Sep 2026
Expected completion
Interventions / Treatments
RituximabSaline (NaCl 0,9 %) (placebo)
Conditions studied
Secondary Progressive Multiple Sclerosis (SPMS)
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
More Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.